A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease

  • STATUS
    Recruiting
  • End date
    Dec 20, 2021
  • participants needed
    500
  • sponsor
    Phathom Pharmaceuticals, Inc.
Updated on 21 August 2021
gastroesophageal reflux
reflux

Summary

The primary objectives of this study are to assess the efficacy of vonoprazan (10 mg, 20 mg, and 40 mg On-Demand) compared to placebo (On-Demand) in relief of episodic heartburn over 6 weeks in participants with symptomatic non-erosive gastroesophageal reflux disease (NERD), and to assess the safety of vonoprazan (10 mg, 20 mg, and 40 mg On-Demand) compared to placebo (On-Demand) in participants with symptomatic NERD.

Details
Condition Heartburn, Heartburn (Pediatric), acidity, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease
Treatment Placebo, Vonoprazan
Clinical Study IdentifierNCT04799158
SponsorPhathom Pharmaceuticals, Inc.
Last Modified on21 August 2021

Eligibility

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note